New hope for ulcerative colitis patients Who've tried everything else
NCT ID NCT06636656
Summary
This study is testing a new drug called BI 3032950 for adults with moderate to severe ulcerative colitis who haven't gotten better with other treatments. Participants first receive the drug through an IV every 4 weeks for 12 weeks, then switch to under-the-skin injections for up to 2 years if they respond. The goal is to see if the drug can reduce symptoms and improve gut health.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Accout Center s.r.o.
Šahy, 936 01, Slovakia
-
Atrium Health
Charlotte, North Carolina, 28204-2963, United States
-
Baylor College of Medicine
Houston, Texas, 77030, United States
-
CHC MontLegia
Liège, 4000, Belgium
-
Centrum Diagnostyczno Lecznicze Barska Sp. z o.o.
Włocławek, 87-800, Poland
-
Centrum Medyczne Medyk Sp. z o.o.
Rzeszów, 35-326, Poland
-
Centrum Medyczne Plejady
Krakow, 30-363, Poland
-
Clinical Center Zemun
Belgrade, 11080, Serbia
-
Clinical Hospital Center Zvezdara
Belgrade, 11000, Serbia
-
Clinical Research Center Sp. z o.o. Medic-R sp.k.
Poznan, 61-731, Poland
-
Clinical Research of Osceola
Kissimmee, Florida, 34741, United States
-
Columbia University Medical Center
New York, New York, 10032-3725, United States
-
Digestive Health Specialists
Tacoma, Washington, 98405-2318, United States
-
EMC Instytut Medyczny S.A. - Poznan 70-304
Poznan, 60-309, Poland
-
EMC Instytut Medyczny S.A. - Wroclaw
Wroclaw, 54-239, Poland
-
ENDOMED s.r.o.
Košice, 040 13, Slovakia
-
Endoskopia Sp. z o.o.
Sopot, 81-756, Poland
-
Eskulap Pabianice Sp. z o.o.
Pabianice, 95-200, Poland
-
F D Roosevelt University General Hospital Of Banska Bystrica
Banská Bystrica, 975 17, Slovakia
-
Florida Research Institute
Lakewood Rch, Florida, 34211, United States
-
Gastro I., s.r.o
Prešov, 080 01, Slovakia
-
Gastromed Sp. z o.o.
Torun, 87-100, Poland
-
General Hospital - Djordje Joanovic
Zrenjanin, 23101, Serbia
-
Hepato-Gastroenterologie HK, s.r.o.
Hradec Králové, 500 12, Czechia
-
ISCARE a.s.
Prague, 190 00, Czechia
-
Illinois Gastroenterology Group - Gurnee
Gurnee, Illinois, 60031, United States
-
KM Management, spol. s.r.o.
Nitra, 949 01, Slovakia
-
Medrise Sp. z o.o.
Lublin, 20-582, Poland
-
Military Medical Academy
Belgrade, 11040, Serbia
-
NZOZ VIVAMED Jadwiga Miecz
Warsaw, 03-580, Poland
-
One of a Kind Clinical Research Center
Scottsdale, Arizona, 85258, United States
-
Peak Gastroenterology Associates
Colorado Springs, Colorado, 80907, United States
-
PlanetMed Sp. z o.o.
Wroclaw, 52-210, Poland
-
Pro Life Medica Sp. z o.o.
Zamość, 22-400, Poland
-
Reliant Medical Research
Miami, Florida, 33165-3639, United States
-
Synexus Polska Sp. z o.o.
Warsaw, 02-672, Poland
-
Texas Digestive Disease Consultants
Cedar Park, Texas, 78613, United States
-
Twoja Przychodnia Szczecinskie Centrum Medyczne Sp. z o.o.
Szczecin, 71-434, Poland
-
UZ Leuven
Leuven, 3000, Belgium
-
University of Kansas Medical Center
Kansas City, Kansas, 66103-2937, United States
-
University of Miami
Miami, Florida, 33136, United States
-
University of Washington
Seattle, Washington, 98195-0001, United States
Conditions
Explore the condition pages connected to this study.